학술논문

JAK1/2 pathway inhibition suppresses M2 polarization and overcomes resistance of myeloma to lenalidomide by reducing TRIB1, MUC1, CD44, CXCL12, and CXCR4 expression
Document Type
Journal
Source
BRITISH JOURNAL OF HAEMATOLOGY; AUG 18 2019, 12p.
Subject
Language
English
ISSN
13652141